scispace - formally typeset
Y

Yeong Shik Kim

Researcher at Seoul National University

Publications -  359
Citations -  15071

Yeong Shik Kim is an academic researcher from Seoul National University. The author has contributed to research in topics: Apoptosis & Nitric oxide synthase. The author has an hindex of 62, co-authored 358 publications receiving 13130 citations. Previous affiliations of Yeong Shik Kim include Inje University & University of Iowa.

Papers
More filters
Journal ArticleDOI

Polysaccharides and phytochemicals: a natural reservoir for the green synthesis of gold and silver nanoparticles

TL;DR: The focus of this review is the application of polysaccharides and phytochemicals in the green synthesis of gold and silver nanoparticles to afford biocomposites with novel uses in nanomedicine and as nanocomposite.
Journal ArticleDOI

Anti-Alzheimer and antioxidant activities of coptidis rhizoma alkaloids.

TL;DR: Goenlandicine may be a promising anti-AD agent due to its potent inhibitory activity of both ChEs and beta-amyloids formation, as well as marked ONOO(-) scavenging and good ROS inhibitory capacities.
Journal ArticleDOI

Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells

TL;DR: The results suggest that the main inhibitory mechanism of the platycodin saponins may be the reduction of iNOS and COX-2 gene expression through blocking of NF-κB activation.
Journal ArticleDOI

Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation

TL;DR: The aromatic diamine JSH‐23 compound exhibited inhibitory effect with an IC50 value of 7.1 μM on nuclear factor (NF)‐κB transcriptional activity in lipopolysaccharide (LPS)‐stimulated macrophages RAW 264.7, and interfered LPS‐induced nuclear translocation of NF‐κBs without affecting IκB degradation.
Journal ArticleDOI

Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill

TL;DR: In vitro results are the first that show that the anti-inflammatory properties of schisandrin result from the inhibition of nitric oxide production, prostaglandin E(2) (PGE(2)) release, cyclooxygenase-2 (COX-2) and inducible Nitric oxide synthase (iNOS) expression.